X
Success comes from listening to and working with patients
https://pharmaphorum.com/views-analysis-patients/success-comes-from-listening-to-and-working-with-patients/
UCB
FDA approves UCB’s Cimzia in plaque psoriasis
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
